[Efficacy of remifentanil in anesthetic management for living-donor renal transplantation].

Background: We used fentanyl and remifentanil in living-donor renal transplantation patients. So, we have compared both drugs in renal function.

Methods: We used the volatile anesthetic sevoflurane as the base in 30 living-donor renal transplantation patients, dividing them into a remifentanil anesthesia group of 15 patients and a fentanyl anesthesia group of 15 patients, and compared their creatinine, BUN, and serum K values before surgery, and 1 day as well as 3 days after surgery.

Results: The results showed improvement in their values, and there were no significant differences between the two groups.

Conclusions: Since more patients in the remifentanil group had adequate diuresis beginning immediately postoperatively without taking a diuretic, remifentanil appears to be a more suitable drug to use for anesthesia for living-donor renal transplantation.